에 대한 최신 뉴스 Reinsurance Gr (NYSE:RGA) 주식

Reinsurance Gr

Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.

Exclusives

Trading Ideas

SCHD

SERA

매주, ‘벤징가의 스톡 위스퍼 지수(Benzinga&#39;s Stock Whisper Index)&#39;는 독점 데이터(proprietary data)와 패턴 인식의 조합을 사용하여 표면 바로 아래에서 주목을 받을 만한 주식 5종목을 소개한다.

벤징가의 &#39;스톡 위스퍼&#39; 지수: 애질런트, 트레이드 데스크, 리인슈런스, 세라 및 슈왑 ETF

Reinsurance Group of America, Incorporated Common Stock

Reinsurance Group of America Inc

Rocket Global Acquisition Corp

RIGAKU HOLDINGS CORP by RIGAKU HOLDINGS CORP.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>B. Riley Securities slashed The Estée Lauder Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) price target from $95 to $70. B. Riley Securities analyst Anna Glaessgen maintained a Neutral rating. Estée Lauder shares closed at $66.58 on Friday. <a href="https://www.benzinga.com/quote/EL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Morgan Stanley raised the price target for Mastercard Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) from $540 to $544. Morgan Stanley analyst James Faucette maintained an Overweight rating. Mastercard shares closed at $508.08 on Friday. <a href="https://www.benzinga.com/quote/MA/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Deutsche Bank cut the price target for Wayfair Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) from $69 to $46. Deutsche Bank analyst Lee Horowitz maintained a Buy rating. Wayfair shares closed at $40.15 on Friday. <a href="https://www.benzinga.com/quote/W/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>RBC Capital increased Reinsurance Group of America, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) price target from $235 to $245. RBC Capital analyst Scott Heleniak maintained an Outperform rating. Reinsurance Group shares settled at $215.10 on Friday. <a href="https://www.benzinga.com/quote/RGA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barrington Research slashed Insight Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSIT#NASDAQ">NSIT</a>) price target from $225 to $205. Barrington Research analyst Vincent Colicchio maintained an Outperform rating. Insight Enterprises shares closed at $172.21 on Friday. <a href="https://www.benzinga.com/quote/NSIT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>DA Davidson raised The Clorox Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) price target from $153 to $171. DA Davidson analyst Linda Bolton Weiser maintained a Neutral rating. Clorox shares closed at $163.11 on Friday. <a href="https://www.benzinga.com/quote/CLX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Craig-Hallum increased the price target for CVRx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVRX#NASDAQ">CVRX</a>) from $15 to $20. Craig-Hallum analyst Alexander Nowak maintained a Buy rating. CVRx shares settled at $13.40 on Friday. <a href="https://www.benzinga.com/quote/CVRX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wedbush cut Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) price target from $62 to $32. Wedbush analyst Matt Bryson maintained a Neutral rating. Super Micro Computer shares closed at $26.05 on Friday. <a href="https://www.benzinga.com/quote/SMCI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Roth MKM lowered the price target for Energy Fuels Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUUU#NYSE">UUUU</a>) from $6 to $5.5. Roth MKM analyst Joe Reagor maintained a Neutral rating. Energy Fuels shares closed at $5.60 on Friday. <a href="https://www.benzinga.com/quote/UUUU/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS boosted Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) price target from $170 to $200. UBS analyst Timothy Arcuri maintained a Buy rating. Broadcom shares closed at $168.92 on Friday. <a href="https://www.benzinga.com/quote/AVGO/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41713185/top-4-tech-and-telecom-stocks-that-may-collapse-this-month">Top 4 Tech And Telecom Stocks That May Collapse This Month</a></li>
</ul>

Price Target

Intraday Update

Markets

Analyst Ratings

AVGO

CVRX

NSIT

SMCI

UUUU

Broadcom To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday

RBC Capital analyst Scott Heleniak maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Outperform and raises the price target from $235 to $245.

News

RBC Capital Maintains Outperform on Reinsurance Gr, Raises Price Target to $245

Each week,&nbsp;Benzinga's Stock Whisper Index&nbsp;uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the&nbsp;<a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">surface and deserve attention</a>.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.
Read Also:&nbsp;<a href="https://www.benzinga.com/top-stories/24/10/41150827/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-september-2024-where-do-tesla-nvidia-apple" target="_blank" rel="noreferrer noopener">EXCLUSIVE – Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?</a>
Here&#8217;s a look at the Benzinga Stock Whisper Index for the week of Nov. 1:
Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) saw increased interest from investors during the week, which comes ahead of several potential catalysts. The life sciences and diagnostics company is set to report fourth-quarter financial results on Nov. 25 and host an analyst day on Dec. 17. Recent <a href="https://www.benzinga.com/quote/A/analyst-ratings">analyst activity</a> on the stock saw Barclays maintain an Underweight rating while raising the price target from $135 to $145. Evercore ISI maintains an In-Line rating while raising the price target from $135 to $145. The stock was up over 3% in the last five trading days as shown on the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110124&amp;t=be2bearmibe3na1">Benzinga Pro chart </a>below. It remains down around 2% year-to-date in 2024.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1001" height="462" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143840/Screenshot-227.png" alt="" class="wp-image-626124" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143840/Screenshot-227.png 1001w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143840/Screenshot-227-300x138.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143840/Screenshot-227-768x354.png 768w" sizes="(max-width: 1001px) 100vw, 1001px" /></a></figure>
Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) saw increased interest from investors ahead of third-quarter financial results, which are set for Nov. 7. Analysts expect the company to report earnings per share of 39 cents and revenue of $619.8 million, compared to earnings of 33 cents per share and revenue of $493.3 million in last year's third quarter. Trade Desk has beaten earnings per share estimates in seven of the last eight quarters and beaten revenue estimates from analysts in more than 10 straight quarters.
Wedbush analyst Daniel Ives <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41144914/meta-trade-desk-amazon-digital-ad-titans-set-for-strong-2025-growth-tech-analyst-sa">recently highlighted </a>the growth potential for Trade Desk in the third quarter.
&#8220;Our survey showed accelerating growth for TTD in 3Q versus 2Q,&#8221; Ives said.
Trade Desk's <a href="https://www.benzinga.com/news/earnings/24/08/40267737/the-trade-desk-stock-climbs-after-better-than-expected-q2-results">second-quarter results</a> saw a customer retention rate of over 95%, continuing a 10-year streak. With potential strong growth and AI initiatives being integrated, the stock could generate some buzz with its third-quarter results.
The stock was down slightly over the last five days, but is up around 70% year-to-date.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="997" height="499" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143856/Screenshot-228.png" alt="" class="wp-image-626125" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143856/Screenshot-228.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143856/Screenshot-228-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143856/Screenshot-228-768x384.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Schwab US Dividend Equity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHD#NYSE">SCHD</a>) made the list for the first time. The Stock Whisper Index typically highlights only stocks and leaves the ETFs out. But each week, ETFs like the SPY, QQQ and sometimes other well-known ETFs see rising interest based on volatility. Schwab tracks the Dow Jones U.S. Dividend 100 Index. It offers investors exposure to some of the largest U.S. companies that pay dividends and have a strong track record of paying out dividends. Top holdings in the ETF include Bristol Myers Squibb, Blackrock, Cisco Systems, Home Depot and Chevron.
With rising global tensions, macroeconomic uncertainties and the 2024 presidential election leaving some investors on edge, the ETF could be seeing increased interest thanks to its dividend income and positions in blue chip companies.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="999" height="512" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143913/Screenshot-229.png" alt="" class="wp-image-626126" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143913/Screenshot-229.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143913/Screenshot-229-300x154.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143913/Screenshot-229-768x394.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
Reinsurance Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>): The life and health reinsurance company saw increased interest over the week likely due to quarterly financial <a href="https://investor.rgare.com/news-releases/news-release-details/reinsurance-group-america-reports-record-third-quarter-results">results</a>. The company reported third-quarter earnings per share of $6.13 and revenue of $5.65 billion, beating Street consensus estimates according to Benzinga Pro. Reinsurance Group's third quarter had record financial results. The strong quarter could put the stock on investors radar for future growth opportunities.
Shares of the reinsurance company were up around 2% for the last five days and are up over 30% year-to-date in 2024.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="995" height="501" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143928/Screenshot-230.png" alt="" class="wp-image-626127" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143928/Screenshot-230.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143928/Screenshot-230-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143928/Screenshot-230-768x387.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>
Sera Prognostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERA#NASDAQ">SERA</a>) is scheduled to report third-quarter financial results on Nov. 6. The company is behind the PreTRM test for pregnancy preterm testing. An investor presentation highlighted the company's future product pipeline to include a predictive analytics product and a time-to-birth test. Shares of the pregnancy diagnostics company were up 16% over the last five trading days.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="999" height="505" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143943/Screenshot-231.png" alt="" class="wp-image-626128" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143943/Screenshot-231.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143943/Screenshot-231-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143943/Screenshot-231-768x388.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
Stay tuned for next week's report, and follow Benzinga Pro for all the latest headlines and&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102524&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">top market-moving stories here.</a>
Read the latest Stock Whisper Index reports here:
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/10/41187322/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">October 4</a></li>
<li><a href="https://www.benzinga.com/top-stories/24/10/41296909/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">October 11</a></li>
<li><a href="https://www.benzinga.com/exclusives/24/10/41405659/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">October 18</a></li>
<li><a href="https://www.benzinga.com/real-estate/reit/24/10/41549488/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">October 25</a></li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/09/40928301/interest-rates-in-free-fall-what-it-means-for-mortgages-credit-cards-and-your-wallet-a" target="_blank" rel="noreferrer noopener">Interest Rates In Free-Fall: What It Means For Mortgages, Credit Cards And Your Wallet</a></li>
</ul>

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

WIIM

Reinsurance Gr shares are trading lower. The company reported Q3 financial results.

Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) reported quarterly earnings of $6.13 per share which beat the analyst consensus estimate of $5.31 by 15.44 percent. The company reported quarterly sales of $5.651 billion which beat the analyst consensus estimate of $5.126 billion by 10.24 percent. This is a 9.66 percent increase over sales of $5.153 billion the same period last year.

Earnings

Earnings Beats

Reinsurance Gr Q3 2024 Adj. EPS $6.13 Beats $5.31 Estimate, Sales $5.651B Beat $5.126B Estimate

Across the recent three months, 12 analysts have shared their insights on Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $240.0, a high estimate of $255.00, and a low estimate of $220.00. This current average has increased by 5.26% from the previous average price target of $228.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1728594037_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Reinsurance Gr. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$244.00</td>
<td>$239.00</td>
</tr>
<tr>
<td>Andrew Kligerman</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Hold</td>
<td>$235.00</td>
<td>-</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$250.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$222.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$242.00</td>
<td>$237.00</td>
</tr>
<tr>
<td>Wilma Burdis</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$250.00</td>
<td>$228.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$255.00</td>
<td>-</td>
</tr>
<tr>
<td>Nigel Dally</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$236.00</td>
<td>$238.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$239.00</td>
<td>$236.00</td>
</tr>
<tr>
<td>Mark Dwelle</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$235.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$220.00</td>
<td>$208.00</td>
</tr>
<tr>
<td>Michael Ward</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$252.00</td>
<td>$194.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Reinsurance Gr. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Reinsurance Gr compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Reinsurance Gr's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Reinsurance Gr's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/RGA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Reinsurance Gr analyst ratings.</a>
<h2>All You Need to Know About Reinsurance Gr</h2>
Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.
<h3>Reinsurance Gr's Economic Impact: An Analysis</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Over the 3 months period, Reinsurance Gr showcased positive performance, achieving a revenue growth rate of 17.4% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: Reinsurance Gr's net margin is impressive, surpassing industry averages. With a net margin of 4.18%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Reinsurance Gr's ROE excels beyond industry benchmarks, reaching 2.11%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Reinsurance Gr's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.19% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.52, caution is advised due to increased financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Reinsurance Gr Stock: Analyst Perspectives (12 Ratings)

Wells Fargo analyst Elyse Greenspan maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Overweight and raises the price target from $239 to $244.

Wells Fargo Maintains Overweight on Reinsurance Gr, Raises Price Target to $244

TD Cowen analyst Andrew Kligerman initiates coverage on Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Hold rating and announces Price Target of $235.

Initiation

TD Cowen Initiates Coverage On Reinsurance Gr with Hold Rating, Announces Price Target of $235

ACGL

ACIC

CINF

ERIE

FIHL

HRTG

KNSL

PLMR

SPNT

Shares of insurance companies are trading lower while Floridians experience evacuation orders as Category 5 Hurricane Milton approaches the state. The region is still recovering from damage due to Hurricane Helene.

JP Morgan analyst Jimmy Bhullar maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Neutral and raises the price target from $220 to $222.

JP Morgan Maintains Neutral on Reinsurance Gr, Raises Price Target to $222

Piper Sandler analyst John Barnidge maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Overweight and raises the price target from $237 to $242.

Piper Sandler Maintains Overweight on Reinsurance Gr, Raises Price Target to $242

Reinsurance Group of America (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rga#NYSE">RGA</a>) shares have rallied 35.1% year to date (YTD) compared with the industry&#39;s growth of 21.5%. The Finance sector and the Zacks S&amp;P 500 index have returned 14.3% and 20% YTD, respectively. With a market capitalization of $14.39 billion, the average volume of shares traded in the last three months was 0.3 million.
<h2>RGA Outperforms Industry, Sector, S&amp;P YTD</h2>
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/01/79471.jpg?v=1113732845" />
Image Source: Zacks Investment Research
The rally was driven by its strong momentum in U.S. Traditional, Longevity/PRT, Asia Asset-Intensive and Asia Traditional, along with solid growth projections.
RGA has a VGM Score of A. VGM Score helps identify stocks with the most attractive value, best growth and the most promising momentum.
<h2>RGA Trading Above 50-Day and 200-Day Moving Average</h2>
This Zacks Rank #3 (Hold) insurance broker closed at $218.58 on Thursday, above its 50-day and 200-day simple moving average&nbsp;of $213.23 and $193.40, respectively, indicating solid upward momentum. SMA is a widely used technical analysis tool to predict future price trends by analyzing historical price data.
<h2>Reinsurance Group&#39;s Earnings Surprise History</h2>
Reinsurance Group has a decent earnings surprise history. Its earnings beat estimates in each of the last four quarters with an average surprise of 20.51%.
<h2>RGA&#39;s Growth Projection Encourages</h2>
The Zacks Consensus Estimate for Reinsurance Group&#39;s 2024 earnings per share indicates a year-over-year increase of 9.1%. The consensus estimate for revenues is pegged at $21.85 billion, implying a year-over-year improvement of 14.7%.
The consensus estimate for 2025 earnings per share indicates a year-over-year increase of 3.4% from the corresponding 2024 estimates.
The expected long-term earnings growth rate is 10.4%, outperforming the industry average of 4.6%. RGA has an impressive Growth Score of B. This style score helps analyze the growth prospects of a company.
<h2>Reinsurance Group&#39;s Return on Invested Capital</h2>
Its return on invested capital has increased every year. This reflects RGA&#39;s efficiency in utilizing funds to generate income. ROIC in the trailing 12 months was 6.8%, higher than the industry average of 0.6%.
<h2>Optimistic Analyst Sentiment for RGA</h2>
Each of the five analysts covering the stock has raised estimates for 2024, and four analysts have raised the same for 2025 over the past 60 days. The consensus estimate for 2024 and 2025 has moved 2.8% and 1.9% north, respectively, in the past 60 days.
<h2>RGA&#39;s Expensive Valuation</h2>
The stock is undervalued compared to its industry. It is currently trading at a price-to-book multiple of 1.46, lower than the industry average of 1.96.
<h2>Will RGA&#39;s Rally Stay?</h2>
Reinsurance Group is a leader in the U.S. and Latin American traditional markets. It has successfully expanded its product line with market-leading services, capabilities, expertise and innovation. Individual mortality has matured and provides a base for stable earnings and capital generation. 
Significant value embedded in the in-force business is anticipated to generate predictable long-term earnings. Product-line expansion contributes to risk diversification.
In Canada, Reinsurance Group is a market leader with solid growth and profitability. It has a sizable block of in-force business, which acts as a significant source of future earnings. Reinsurance Group expects longevity insurance, which is projected to witness steady demand, to experience long-term growth in the Canadian market. While longevity insurance provides a source of diversified income, it also acts as a hedge to a large mortality position.
Demand for protection products among the emerging global middle class and increasing demand for retirement, senior protection and savings products among aging populations create opportunities for growth in new business.
RGA is well-capitalized and has access to multiple forms of capital. RGA expects to remain active in deploying capital in attractive growth opportunities while balancing returning excess capital to shareholders over time.
RGA continues to ramp up technological inclusion with its product. This insurer is a global biometric liability reinsurance leader. Biometrics experience, which includes mortality, morbidity and longevity, over the last five quarters was favorable. Notably, its free cash flow conversion has remained more than 85% over the last many quarters, reflecting its solid earnings.
<h2>Wealth Distribution</h2>
This global reinsurer has also been managing capital effectively via share buybacks, dividend payments and prudent investments. RGA expects to remain active in deploying capital into attractive growth opportunities in organic flow and in-force block transactions and returning excess capital to shareholders through dividends and share repurchases. The company exited the second quarter of 2024 with excess capital of around $1 billion, reflecting a solid capital position.
<h2>Key Picks</h2>
Investors interested in the life insurance industry may look at some better-ranked players like Baldwin Insurance Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bwin#NASDAQ">BWIN</a>), Brighthouse Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bhf#NASDAQ">BHF</a>) and Primerica, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pri#NYSE">PRI</a>), each carrying a Zacks Rank #2 (Buy) at present.
The Zacks Consensus Estimate for Baldwin Insurance&#39;s 2024 and 2025 earnings implies year-over-year growth of 38.3% and 32.2%, respectively. BWIN beat earnings estimates in each of the past four quarters, with an average surprise of 11.88%. Year to date, shares of BWIN have gained 108.4%.
The Zacks Consensus Estimate for Brighthouse Financial&#39;s 2024 and 2025 earnings implies year-over-year growth of 29.8% and 9.1%, respectively. It beat earnings estimates in three of the past four quarters while missing in one, with an average surprise of 3.76%. Year to date, shares of BHF have lost 16.3%.
The Zacks Consensus Estimate for Primerica&#39;s 2024 and 2025 earnings implies year-over-year growth of 12.2% and 10.9%, respectively. It beat earnings estimates in two of the past four quarters and missed in two, with an average surprise of 1.74%. Year to date, shares of PRI have climbed 29.6%.
<a href="https://www.zacks.com/stock/news/2342526/reinsurance-group-rallies-35-1-ytd-what-s-driving-the-stock?cid=CS-BENZ-FT-analyst_blog|price_surge_/_plunge-2342526">To read this article on Zacks.com click here.</a>

Large Cap

Mid Cap

Dividends

Health Care

Small Cap

Insurance

General

Brighthouse Financial, Inc. - Common Stock

BWIN

Reinsurance Group Rallies 35.1% YTD: What's Driving the Stock?

During the last three months, 12 analysts shared their evaluations of Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $221.5, a high estimate of $255.00, and a low estimate of $64.00. Witnessing a positive shift, the current average has risen by 7.29% from the previous average price target of $206.45.
<img src="https://www.benzinga.com/files/images/story/2024/1727204428_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Reinsurance Gr. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Wilma Burdis</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$250.00</td>
<td>$228.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$255.00</td>
<td>-</td>
</tr>
<tr>
<td>Nigel Dally</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$236.00</td>
<td>$238.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$239.00</td>
<td>$236.00</td>
</tr>
<tr>
<td>Mark Dwelle</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$235.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$220.00</td>
<td>$208.00</td>
</tr>
<tr>
<td>Michael Ward</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$252.00</td>
<td>$194.00</td>
</tr>
<tr>
<td>Suneet Kamath</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$64.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Nigel Dally</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$217.00</td>
<td>$216.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$208.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Suneet Kamath</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$247.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$235.00</td>
<td>$228.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Reinsurance Gr. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Reinsurance Gr compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Reinsurance Gr's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Reinsurance Gr's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/RGA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Reinsurance Gr analyst ratings.</a>
<h2>Delving into Reinsurance Gr's Background</h2>
Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.
<h3>Financial Milestones: Reinsurance Gr's Journey</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Positive Revenue Trend: Examining Reinsurance Gr's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 17.4% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Reinsurance Gr's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 4.18%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Reinsurance Gr's ROE stands out, surpassing industry averages. With an impressive ROE of 2.11%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Reinsurance Gr's ROA stands out, surpassing industry averages. With an impressive ROA of 0.19%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Reinsurance Gr's debt-to-equity ratio stands notably higher than the industry average, reaching 0.52. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>What Are Analyst Ratings?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cracking The Code: Understanding Analyst Reviews For Reinsurance Gr

Raymond James analyst Wilma Burdis maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Strong Buy and raises the price target from $228 to $250.

Raymond James Maintains Strong Buy on Reinsurance Gr, Raises Price Target to $250

Barclays analyst Alex Scott initiates coverage on Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Overweight rating and announces Price Target of $255.

Barclays Initiates Coverage On Reinsurance Gr with Overweight Rating, Announces Price Target of $255

Reinsurance Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) short percent of float has fallen 18.84% since its last report. The company recently reported that it has 281 thousand shares sold short, which is 0.56% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Reinsurance Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725390021_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Reinsurance Gr has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Reinsurance Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Reinsurance Gr's peer group average for short interest as a percentage of float is 1.93%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

(RGA) - Analyzing Reinsurance Gr's Short Interest

Morgan Stanley analyst Nigel Dally maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Equal-Weight and lowers the price target from $238 to $236.

Morgan Stanley Maintains Equal-Weight on Reinsurance Gr, Lowers Price Target to $236

Sun Life Financial (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/slf#NYSE">SLF</a>) has been benefiting from its focus on Asia operations, growing asset management businesses and the scale-up and integration of U.S. operations. Earnings of SLF have risen 5.4% over the last five years.
This third-largest insurer in Canada has a decent earnings surprise history. It surpassed estimates in three of the last four quarters and missed in one, the average earnings surprise being 1.76%.
Sun Life&#39;s focus on the emerging economies of Asia that are expected to provide higher returns and the North American markets bodes well for long-term growth. SLF has a strong presence in China, Philippines, India, Hong Kong and Indonesia and has also forayed into Malaysia and Vietnam. Contribution from Asia business to Sun Life&#39;s earnings has increased to 21% over the last few years.
Sun Life envisions being one of the top five players and remains focused on growing its voluntary benefits business. The life insurer is also improving its business mix and is thus shifting its growth focus toward products that block lower capital and offer more predictable earnings.
Sun Life Investment Management makes investments in private fixed-income mortgages and real estate. It invests in pension plans and other institutional investors. These are indicative of SLF&#39;s efforts to strengthen Asset Management, which provides a higher return on equity, requires lower capital and sees lesser volatility and has the potential for an earnings upside.
Operational efficiency has been aiding Sun Life in building a strong capital position. The life insurer&#39;s capital outlay includes a 40-50% dividend payout over the medium term.
However, expenses have increased at Sun Life over the past few years due to high employee expenses, premises and equipment, service fees, amortization of intangible assets and other expenses. These, in turn, weigh on margin expansion. The life insurer remains committed toward balancing both metrics, failing which, the bottom line might suffer. The company estimates integration activities to drive run-rate cost savings of $60 million by 2024.
Nonetheless, SLF&#39;s trailing 12-month return on equity was 17.5%, ahead of the industry average of 15.5%. Return on equity, a profitability measure, reflects how effectively a company is utilizing its shareholders&#39; funds. Given the company&#39;s ongoing shift to fee-based capital-light businesses, SLF reiterated its medium-term ROE target of 18%.
Also, the return on invested capital in the trailing 12 months was 0.8%, better than the industry average of 0.7%. This reflects SLF&#39;s efficiency in utilizing funds to generate income.&nbsp;
<h3>Some Key Industry Players</h3>
Other players in the insurance industry are Brighthouse Financial (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bhf#NASDAQ">BHF</a>), Reinsurance Group of America, Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rga#NYSE">RGA</a>) and Primerica (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pri#NYSE">PRI</a>).
Brighthouse Financial&#39;s earnings surpassed estimates in three of the last four quarters and missed in one, the average surprise being 3.76%.
With an expansive and compelling suite of life and annuity products and a strong market presence, BHF aims to become a premier player in the individual insurance market.&nbsp; Brighthouse is also revamping its life insurance business to boost annuity sales. Sales of Shield Level annuities and variable annuities with FlexChoice Access should drive Annuity sales.&nbsp; The insurer remains focused on transitioning the business mix to less capital-intensive products.
Reinsurance Group&#39;s earnings surpassed estimates in each of the last four quarters, the average surprise being 20.51%.
RGA has been benefiting from an increase in new business volumes, favorable longevity experience, a stronger invested asset base, business expansion in the pension risk transfer market and effective capital deployment.
Primerica&#39;s earnings surpassed estimates in three of the last four quarters and missed in one, the average surprise being 1.74%.
This second-largest issuer of term-life insurance coverage in North America aims to be a successful senior health business while continuing to enhance its shareholders&#39; value. Strong demand for protection products drives sales growth and policy persistency benefit the life insurer. A strong business model makes Primerica well-poised to cater to the middle market&#39;s increased demand for financial security.
<a href="https://www.zacks.com/stock/news/2322684/sun-life-slf-grows-on-solid-asia-business-amid-cost-woes?cid=CS-BENZ-FT-analyst_blog|zer_report_update-2322684">To read this article on Zacks.com click here.</a>

Asia

Management

Sun Life Grows on Solid Asia Business Amid Cost Woes

Sun Life Financial Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/slf#NYSE">SLF</a>) delivered second-quarter 2024 underlying net income of $1.25 per share, which beat the Zacks Consensus Estimate by 5.9%. The bottom line increased 6.8% year over year. Underlying net income was $730.8 million (C$1 billion), which increased 9% year over year.
Results reflected continued solid growth in Canada and Asia. The U.S. also saw favorable experience in Group Benefits, partially offset by residual headwinds in dental.
Revenues of $6.5 billion increased 14.2% year over year but missed the Zacks Consensus Estimate by 3%.
Wealth sales &amp; asset management gross flows of $33.8 billion (C$46.3 billion) increased 9.1% year over year. Group - Health &amp; Protection sales of $362.5 million (C$496 million) decreased 17.7% year over year. Individual - Protection sales of $550.3 million (C$753 million) jumped 24.7% year over year.
New business contractual service margin was $319.4 million (C$437 million), up 61.9% year over year.
<div class="chart_embed">
<h3>Sun Life Financial Inc. Price, Consensus and EPS Surprise</h3>
<h3><img alt="Sun Life Financial Inc. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/15/1723558499.png" style="height:265px; width:574px" title="" /></h3>
Sun Life Financial Inc. price-consensus-eps-surprise-chart | Sun Life Financial Inc. Quote
</div>
<h3>Segment Results</h3>
SLF Canada&#39;s underlying net income increased 8% year over year to $294 million (C$402 million). Canada witnessed solid results at Wealth &amp; Asset Management and Individual - Protection.
Wealth sales &amp; asset management gross flows of $3.6 billion ($5 billion) climbed 72% year over year. Group - Health &amp; Protection increased year over year but Individual - Protection sales declined.
SLF U.S.&#39; underlying net income was $149 million, which decreased 5% year over year, reflecting soft results at Individual &ndash; Protection and Group - Health &amp; Protection.
U.S. group sales of $243 million decreased 22%, reflecting lower Medicare and Medicaid sales in Dental due to large institutional sales in the prior year, partially offset by higher medical stop-loss sales.
SLF Asset Management reported underlying net income of $224.3 million (C$307 million), which increased 4% year over year, attributable to stable results in MFS. Asset Management exited the reported quarter with $0.8 trillion (C$1.072 trillion) of AUM, comprising $618 billion in MFS and $165.9 billion (C$227 billion) in SLC Management.
SLF Asia reported underlying net income of $130.8 million (C$179 million), which grew 19% year over year, driven by solid results at Wealth &amp; asset management and Individual - Protection.
Individual sales of $428 million (C$586 million) jumped 30% year over year. Wealth sales &amp; asset management gross flows of $1.5 billion ($2 billion) increased 24% year over year. New busines
New business CSM of $160.8 million (C$220 million) increased 86.4% year over year, primarily driven by sales in Hong Kong.
<h3>Financial Update &nbsp;</h3>
Global assets under management were $1.1 billion (C$1.465 trillion), up 7% year over year.
Sun Life Assurance&#39;s Life Insurance Capital Adequacy Test (LICAT) ratio was 142% as of Jun 30, 2024, up 300 basis points (bps) from Jun 30, 2023, level.
The LICAT ratio for Sun Life (including cash and other liquid assets) was 150%, which expanded 20 bps year over year.
Sun Life&#39;s return on equity was 11.7% in the second quarter of 2024, which contracted 100 bps year over year. The underlying return on equity of 18.1% expanded 40 bps year over year. The leverage ratio of 22.61% improved 70 bps from Jun 30, 2023, level.
<h3>Dividend Update</h3>
The company&#39;s board of directors approved a quarterly dividend of 81 cents per share. The amount will be paid out on Sep 27, 2024, to shareholders of record at the close of business on Aug 28.
<h3>Zacks Rank</h3>
Sun Life currently carries a Zacks Rank #4 (Sell).
<h3>Performance of Other Insurers</h3>
Voya Financial, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/voya#NYSE">VOYA</a>) reported second-quarter 2024 adjusted operating earnings of $2.27 per share, which beat the Zacks Consensus Estimate by 3.6%. The bottom line, however, decreased 1.7% year over year. Adjusted operating revenues amounted to $324 million, down 6.6% year over year. The top line missed the Zacks Consensus Estimate by 0.4%.
Net investment income declined 5% year over year to $518 million. Premiums totaled $790 million, up 16.7% from the year-ago quarter. As of Jun 30, 2024, VOYA&#39;s assets under management, assets under administration and advisement totaled $861.3 billion.
Reinsurance Group of America, Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rga#NYSE">RGA</a>) reported second-quarter 2024 adjusted operating earnings of $5.48 per share, which beat the Zacks Consensus Estimate by 10.9%. The bottom line increased 24.5% from the year-ago quarter. RGA&#39;s operating revenues of $5.1 billion improved 20.3% year over year, driven by higher net premiums, investment income, net of related expenses and other revenues. It beat the consensus estimate by 4.7%.
Net premiums of $3.9 billion jumped 17.5% year over year. RGA deployed $307 million for in-force transactions. Investment income and net of related expenses increased 26.3% from the prior-year quarter to $1.1 billion. The average investment yield increased 23 basis points to 4.65%, primarily due to higher new money rates.
Lincoln National Corporation&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lnc#NYSE">LNC</a>) second-quarter 2024 adjusted earnings of $1.84 per share beat the Zacks Consensus Estimate by 3.4%. However, the bottom line declined 8.9% year over year. Adjusted operating revenues of $4.5 billion dropped 4.3% year over year in the quarter under review. The top line lagged the consensus mark by 2.7%.
Fee income declined 1.9% year over year to $1.3 billion, which missed the Zacks Consensus Estimate by 2.1%. Insurance premiums of $1.6 billion rose 0.8% year over year. The metric beat the consensus mark by 0.7%. LNC&#39;s net investment income of $1.3 billion declined 11.7% year over year and missed the consensus mark by 1.7%. Meanwhile, other revenues fell 5.9% year over year.
<a href="https://www.zacks.com/stock/news/2321448/sun-life-slf-q2-earnings-beat-revenues-miss-estimates?cid=CS-BENZ-FT-analyst_blog|earnings_article-2321448">To read this article on Zacks.com click here.</a>

VOYA

Sun Life Q2 Earnings Beat, Revenues Miss Estimates

Wells Fargo analyst Elyse Greenspan maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Overweight and raises the price target from $236 to $239.

Wells Fargo Maintains Overweight on Reinsurance Gr, Raises Price Target to $239

Reinsurance Group ( ($RGA) ) has shared an announcement. Reinsurance Group of America, a prominent provider in life and health reinsurance, reporte...

Reinsurance Group Reports Strong Third-Quarter Results

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Dun & Bradstreet Holdings (DNB – Research Report), ...

Analysts Offer Insights on Financial Companies: Dun & Bradstreet Holdings (DNB), Reinsurance Group (RGA) and TMX Group (OtherTMXXF)

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Reinsurance Group (RGA – Research Report), First Mi...

Analysts Conflicted on These Financial Names: Reinsurance Group (RGA), First Mid-Illinois Bancshares (FMBH) and USCB Financial Holdings, Inc. Class A (USCB)

In a report released today, Bob Huang from Morgan Stanley maintained a Hold rating on Reinsurance Group (RGA – Research Report), with a price targe...

Morgan Stanley Reaffirms Their Hold Rating on Reinsurance Group (RGA)

Reinsurance Group of America, Incorporated 2024 Q3 - Results - Earnings Call Presentation

Reinsurance Group of America, Incorporated (RGA) Q3 2024 Earnings Call Transcript

Reinsurance Group of America declares $0.89 dividend

Reinsurance Group Of America ( ($RGA) ) has released its Q3 earnings. Here is a breakdown of the information Reinsurance Group Of America presented...

Reinsurance Group of America Shows Record Quarterly Results

RBC Capital analyst Scott Heleniak maintained a Buy rating on Reinsurance Group (RGA – Research Report) today and set a price target of $245.00. Th...

RBC Capital Sticks to Their Buy Rating for Reinsurance Group (RGA)

RBC Capital raised the firm's price target on Reinsurance Group (RGA) to $245 from $235 and keeps an Outperform rating on the shares. The company r...

Reinsurance Group price target raised to $245 from $235 at RBC Capital

FMBH

TMXXF

USCB

Press Releases

AM Best Assigns Issue Credit Rating to Reinsurance Group of America, Incorporated's New Senior Unsecured Notes

Axel André Joins RGA to Succeed Todd Larson as Chief Financial Officer

Reinsurance Group of America Announces Second Quarter Earnings Release Date, Webcast

RGA Leaders of Tomorrow Program Celebrates 10 Years of Inspiring Future Insurance Executives

Reinsurance Group of America Reports Second Quarter Results

RGA Announces $3.5 Billion Coinsurance Transaction with American National Insurance Company

Behavioral Science in Life Insurance Focus of New Study from Society of Actuaries Research Institute

Reinsurance Group of America Announces Third Quarter Earnings Release Date, Webcast

IIS Announces 2024 RGA Leaders of Tomorrow Finalists: Industry's Rising Stars Address Leadership, Financial Literacy, and the Protection Gap

Reinsurance Group of America Reports Record Third Quarter Results

Everest Group

Enstar Gr

Greenlight Reinsurance, Ltd. - Class A Ordinary Shares

Greenlight Capital Re

Maiden Hldgs

Oxbridge Re Holdings Limited - Ordinary Shares

Oxbridge Re Holdings

RenaissanceRe Holdings

SiriusPoint

RBC Capital

Wells Fargo

TD Cowen

Barclays

JP Morgan

매주, ‘벤징가의 스톡 위스퍼 지수(Benzinga's Stock Whisper Index)'는 독점 데이터(proprietary data)와 패턴 인식의 조합을 사용하여 <a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">표면 바로 아래에서 주목</a>을 받을 만한 주식 5종목을 소개한다.
투자자들은 가치가 저평가된, 관심이 적은, 새로운 주식들을 항상 찾고 있다. 소매 거래자들이 사용할 수 있는 방법은 무수히 많기 때문에 새로운 기회를 발견하고 특정 주식이 관심을 가져야 하는 이유를 이해하기 위해 풍부한 정보를 조사하는 것이 어려운 경우가 많다.
다음은 11월 1일 주간 벤징 &#8216;주식 위스퍼&#8217; 지수의 개요:
애질런트 테크놀로지스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>):
투자자들의 관심이 증가하고 있으며, 이는 여러 잠재적 촉매제가 앞두고 있기 때문이다. 생명과학 및 진단 회사인 애질런트는 11월 25일에 4분기 재무 결과를 발표하고, 12월 17일에 애널리스트 데이를 개최할 예정이다. <a href="https://www.benzinga.com/quote/A/analyst-ratings" target="_blank" rel="noopener" data-google-interstitial="false">최근</a> 바클레이즈가 이 주식에 대해 비중축소(Underweight) 등급을 유지하면서 목표 주가를 135달러에서 145달러로 상향 조정한 후 주가가 상승했다. 에버코어 ISI는 인라인 등급을 유지하면서도 목표 주가를 135달러에서 145달러로 상향 조정했다. 주가는 금요일 5.03% 상승한 136.87달러에 마감했다. 지난 5거래일 동안 4.08% 상승했으며, 2024년 현재 연초 대비 1.35% 하락한 상태다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143840/Screenshot-227.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
트레이드 데스크(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>):
3분기 재무 결과 발표를 앞두고 투자자들의 관심이 증가했다. 11월 7일에 3분기 실적이 발표될 예정이며, 애널리스트들은 주당 39센트의 이익과 6억 1,980만 달러의 매출을 예상하고 있다. 이는 작년 3분기 주당 33센트의 이익과 4억 9,330만 달러의 매출과 비교된다. 트레이드 데스크는 최근 8개 분기 중 7개 분기에서 주당 이익 추정치를 초과했으며, 매출 추정치는 10개 분기 이상 초과했다.
웨드부시(Wedbush)의 애널리스트인 댄 아이브스는 트레이드 데스크의 성장 잠재력을 <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41144914/meta-trade-desk-amazon-digital-ad-titans-set-for-strong-2025-growth-tech-analyst-sa" target="_blank" rel="noopener" data-google-interstitial="false">강조</a>했다.
아이브스는 &#8220;우리 조사에 따르면 2분기 대비 3분기에 TTD의 성장이 가속화되는 것으로 나타났다&#8221;고 말했다.
트레이드 데스크의 <a href="https://www.benzinga.com/news/earnings/24/08/40267737/the-trade-desk-stock-climbs-after-better-than-expected-q2-results" target="_blank" rel="noopener" data-google-interstitial="false">2분기 실적</a>에 따르면 고객 유지율은 95%가 넘으며 10년 연속 이어졌다. 잠재적인 강력한 성장과 인공지능(AI) 이니셔티브가 통합되면서 주식은 3분기 실적에 대해 약간의 화제를 불러일으킬 수 있다.
주가는 금요일 0.85% 하락한 119.19달러에 마감되었다. 지난 5일 동안 0.82% 하락했으나, 2024년 연초 대비 68.85% 상승했다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143856/Screenshot-228.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
Schwab US Dividend Equity ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHD#NYSE">SCHD</a>):
이 ETF가 처음으로 리스트에 등장했다. 스톡 위스퍼 지수는 일반적으로 주식만 강조하고 ETF는 제외하지만, 매주 SPY, QQQ와 같은 잘 알려진 ETF들이 변동성을 기반으로 관심이 상승하는 경우가 있다. 슈왑(Schwab)은 Dow Jones U.S. Dividend 100 Index를 추적한다. 이는 배당금을 지급하고 배당금 지급 실적이 우수한 미국 대기업들에 대한 노출을 제공한다. 이 ETF의 주요 보유 종목에는 브리스톨 마이어스 스퀴브(Bristol Myers Squibb), 블랙록, 시스코 시스템즈, 홈 디포 및 쉐브론이 포함된다.
글로벌 긴장 고조, 거시경제 불확실성, 2024년 대통령 선거로 인해 일부 투자자들이 불안해하는 상황에서, 이 ETF가 배당 소득과 블루칩 회사들에 대한 투자로 인해 관심이 증가하고 있을 수 있다.
이 ETF는 금요일 0.46% 하락한 28.10달러에 마감되었다. 올해 들어 9.94% 올랐다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143913/Screenshot-229.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
리인슈런스 그룹(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>):
생명 및 건강 재보험 회사로, 분기 재무 <a href="https://investor.rgare.com/news-releases/news-release-details/reinsurance-group-america-reports-record-third-quarter-results" target="_blank" rel="noopener">결과</a>로 인해 투자자들의 관심이 증가했다. 이 회사는 3분기 주당 6.13달러의 이익과 56억 5천만 달러의 매출을 기록했으며, 이는 월스트리트 컨센서스 예상을 초과한 결과이다. 리인슈런스 그룹의 3분기는 기록적인 재무 결과를 기록했다. 이 강력한 분기는 주식이 향후 성장 기회에 대한 투자자들의 레이더에 오르는 데 도움이 될 수 있다.
주가는 금요일 1.90% 상승한 215.10달러에 마감되었다. 지난 5일 동안 1.37% 상승했으며, 2024년 연초 대비 31.83% 상승했다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143928/Screenshot-230.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
세라 프로그노스틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERA#NASDAQ">SERA</a>):
3분기 재무 결과를 11월 6일에 발표할 예정이다. 이 회사는 임신 조기 출산 테스트를 위한 PreTRM 테스트를 개발했다. 투자자 발표에서는 이 회사의 미래 제품 파이프라인에 대한 설명도 있었으며, 예측 분석 제품과 출산 시기 테스트가 포함될 예정이다.
이 임신 진단 회사의 주가는 금요일 1.56% 상승한 7.81달러에 마감되었다. 지난 5거래일 동안 16.57% 상승했다. 2024년 연초 대비 30.82% 상승했다.
다음 주 보고서를 계속 지켜봐 주시기 바랍니다. 여기에서 Benzinga Pro를 팔로우하여 모든 최신 헤드라인과 <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102524&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">시장을 움직이는 주요 스토리</a>를 확인하세요.
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Reinsurance Gr

뉴스

에 대한 최신 뉴스 Reinsurance Gr (NYSE:RGA) 주식

토요일, 11월 02, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌